About
Ultrasensitive multiplex assay for detecting rare nucleic acid sequences in biological samples
Areas of Focus
Categories
Diagnostics
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
140
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06471543Lead Sponsor
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
PHASE1/PHASE2Recruiting
108 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2026
NCT05905068Lead Sponsor
Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects
PHASE1Completed
32 participants
Started: Jul 14, 2023 · Completed: May 14, 2024
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...